Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO - a Report from the Children's Oncology Group

Blood (2024) 144 (Supplement 1): 967.

https://doi.org/10.1182/blood-2024-205666

Published: 2024

Journal Articles

Molecular Features, Treatments and Outcomes for Pediatric AML Patients from APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial

Michele S. Redell, Robert Gerbing, Todd A. Alonzo, Jim Wang, Maureen O'Brien, Sarah K. Tasian, Matthew A. Kutny, Todd M Cooper

Blood (2024) 144 (Supplement 1): 4233.

https://doi.org/10.1182/blood-2024-200978

Published: 2024

Journal Articles

Anti-Leukemic Activity of Luveltamab Tazevibulin (LT, STRO-002), a Novel Folate Receptor-α (FR-α)-Targeting Antibody Drug Conjugate (ADC) in Relapsed/Refractory CBF2AT3::GLIS2 AML

Blood (2023) 142 (Supplement 1): 4295.

https://doi.org/10.1182/blood-2023-180141

Published: 2023

Journal Articles

Expanding the High-Risk Definition for Children with Newly Diagnosed Acute Myeloid Leukemia

Adam J. Lamble, Rhonda E. Ries, Todd A. Alonzo, Yi-Cheng Wang, Jason E Farrar, Benjamin J. Huang, Matthew A. Kutny, Jessica A. Pollard, Richard Aplenc, Alan S. Gamis, Edward A. Kolb, Todd M. Cooper, Soheil Meshinchi

Blood (2022) 140 (Supplement 1): 3393–3394.

https://doi.org/10.1182/blood-2022-167680

Published: 2022

Journal Articles

Characteristics and Prognostic Effects of IDH Mutations across the Age Spectrum in AML: A Collaborative Analysis from COG, SWOG, and ECOG

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-134211

Published: 2020

Journal Articles

Temporal Trends in Early Mortality in Acute Promyelocytic Leukemia in the United States

Ana C. Xavier, MD, Matthew A. Kutny, MD, Omer Jamy, MD, Luciano J Costa, MD PhD

Blood (2018) 132 (Supplement 1): 710.

https://doi.org/10.1182/blood-2018-99-114171

Published: 2018

Journal Articles

Outcomes Based on CNS Disease Status in Pediatric Acute Myeloid Leukemia and the Role of Peripheral Blood Contamination in Diagnostic Lumbar Punctures; A Report from the Children's Oncology Group Studies AAML0531 and AAML1031

Matthew A. Kutny, MD, Todd A Alonzo, PhD, Robert B Gerbing, Yi-Cheng Wang, Richard Aplenc, MD, Alan S Gamis, MD MPH, James Feusner, William G. Woods, MD, Soheil Meshinchi, MD PhD, Donna Johnston, MDFRCPC

Blood (2017) 130 (Supplement 1): 3859.

https://doi.org/10.1182/blood.V130.Suppl_1.3859.3859

Published: 2017

Journal Articles

Targeting PRMT1 As a Novel Curative Therapy for Acute Myeloid Leukemia

Hairui Su, BS, PhD, Shuiling Jin, PhD, Yudao Shen, Matthew A. Kutny, MD, Jian Jin, PhD, Minkui Luo, Xinyang Zhao, PhD

Blood (2017) 130 (Supplement 1): 2650.

https://doi.org/10.1182/blood.V130.Suppl_1.2650.2650

Published: 2017

Journal Articles

Genomic Subtypes of Nucleophosmin (NPM1) Mutations Are Associated with Clinical Outcome in AML - a COG and SWOG Intergroup Collaboration

Dalia Selim, MD, Todd A. Alonzo, PhD, Megan Othus, PhD, Robert Gerbing, BS, Fabiana Ostronoff, MD, Katherine Tarlock, MD, Matthew A. Kutny, MD, Richard Aplenc, MD PhD, E. Anders Kolb, MD, Jerald P. Radich, MD, Frederick R. Appelbaum, MD, Alan S. Gamis, MD MPH, Derek L. Stirewalt, Soheil Meshinchi, MD PhD

Blood (2016) 128 (22): 285.

https://doi.org/10.1182/blood.V128.22.285.285

Published: 2016

Journal Articles

FLT3 Mutations in Pediatric Acute Promyelocytic Leukemia; A Report from the Children's Oncology Group AAML0631 Trial

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert Gerbing, BS, Yi-Cheng Wang, Cecilia Fu, MD, Alan S. Gamis, MD MPH, E. Anders Kolb, MD, James H. Feusner, MD, John Gregory, Jr., MD, Soheil Meshinchi, MD PhD

Blood (2016) 128 (22): 2884.

https://doi.org/10.1182/blood.V128.22.2884.2884

Published: 2016

Journal Articles

Malignancy Risk Markers in a Cohort of Referrals for Lymphadenopathy; An Evaluation of Clinical Features Including Lymph Node Size

Orlando Esparza, MD, Ana Xavier, MD, Matthew A. Kutny, MD, Julie A. Wolfson, MD, Jeffrey D. Lebensburger, DO MSPH

Blood (2016) 128 (22): 2385.

https://doi.org/10.1182/blood.V128.22.2385.2385

Published: 2016

Journal Articles

TET2 Mutations Are Highly Associated with RUNX1-RUNX1T1 Translocations and NPMc+ in Childhood AML: a Report from Children's Oncology Group AAML03P1, AAML0531 and NCI/COG Target AML Initiative

Blood (2015) 126 (23): 1368.

https://doi.org/10.1182/blood.V126.23.1368.1368

Published: 2015

Journal Articles

Defining the Genomic Make up of Acute Myeloid Leukemia in Adolescents and Young Adults (AYA): Report from COG AAML03P1, AAML531 and SWOG S0106

Fabiana Ostronoff, MD, Todd A. Alonzo, PhD, Megan Othus, PhD, Matthew A. Kutny, MD, Robert B. Gerbing, MA, Jerald P. Radich, MD, Harry P Erba, MD PhD, Frederick R. Appelbaum, MD, E. Anders Kolb, MD, Alan S. Gamis, MD MPH, Derek L. Stirewalt, MD, Soheil Meshinchi, MD PhD

Blood (2015) 126 (23): 2576.

https://doi.org/10.1182/blood.V126.23.2576.2576

Published: 2015

Journal Articles

Results of a Phase III Trial Including Arsenic Trioxide Consolidation for Pediatric Patients with Acute Promyelocytic Leukemia (APL): A Report from the Children's Oncology Group Study AAML0631

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Yi-Cheng Wang, MS, Cecilia Fu, MD, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH, James H. Feusner, MD, John Gregory, Jr., MD

Blood (2015) 126 (23): 219.

https://doi.org/10.1182/blood.V126.23.219.219

Published: 2015

Journal Articles

Comprehensive Genomic and Transcript Profiling of CBL Gene in Childhood AML: A Report from Children's Oncology Group Studies AAML03P1, AAML0531 and COG/NCI Target AML Initiative

Blood (2015) 126 (23): 170.

https://doi.org/10.1182/blood.V126.23.170.170

Published: 2015

Journal Articles

Arsenic Trioxide Is a Well Tolerated Consolidation Regimen in Children with Newly Diagnosed Acute Promyelocytic Leukemia; Toxicity Results of the Children’s Oncology Group AAML0631 Trial

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Yi-Cheng Wang, MS, Cecilia Fu, MD, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH, James H. Feusner, MD, John Gregory, MD

Blood (2014) 124 (21): 985.

https://doi.org/10.1182/blood.V124.21.985.985

Published: 2014

Journal Articles

Effect of Young Age on Outcomes in Pediatric Acute Promyelocytic Leukemia (APL): North American Intergroup Study CALGB 9710 (Alliance)

Matthew A. Kutny, MD, Susan Geyer, PhD, Kristina M Laumann, BA, John Gregory, MD, Cheryl L. Willman, MD, Wendy Stock, MD, Richard A. Larson, Bayard L. Powell, MD, James H. Feusner, MD

Blood (2014) 124 (21): 2301.

https://doi.org/10.1182/blood.V124.21.2301.2301

Published: 2014

Journal Articles

A Comparison of Outcomes Between Adolescents and Young Adults (AYA) and Children with Acute Promyelocytic Leukemia (APL): North American Intergroup Study CALGB 9710 (Alliance)

Matthew A. Kutny, MD, Susan Geyer, PhD, Kristina M Laumann, BA, John Gregory, MD, Cheryl L. Willman, MD, Wendy Stock, MD, Richard A. Larson, Bayard L. Powell, MD, James H. Feusner, MD

Blood (2014) 124 (21): 2306.

https://doi.org/10.1182/blood.V124.21.2306.2306

Published: 2014

Journal Articles

Incidence and Outcomes of Pediatric Myelodysplastic Syndrome in the US

Ana Xavier, MD, Matthew A. Kutny, MD, Luciano J Costa, MD PhD

Blood (2014) 124 (21): 1285.

https://doi.org/10.1182/blood.V124.21.1285.1285

Published: 2014

Journal Articles

Evaluation of ISTH DIC Score to Predict Significant Bleeding and Thrombosis Events in Pediatric Acute Promyelocytic Leukemia; A Report from the Children’s Oncology Group AAML0631 Trial

Matthew A. Kutny, MD, Madhvi Rajpurkar, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Alan S. Gamis, MD MPH, James H. Feusner, MD, John Gregory, MD

Blood (2014) 124 (21): 3669.

https://doi.org/10.1182/blood.V124.21.3669.3669

Published: 2014

NARROW

A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO - a Report from the Children's Oncology Group

Molecular Features, Treatments and Outcomes for Pediatric AML Patients from APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial

Anti-Leukemic Activity of Luveltamab Tazevibulin (LT, STRO-002), a Novel Folate Receptor-α (FR-α)-Targeting Antibody Drug Conjugate (ADC) in Relapsed/Refractory CBF2AT3::GLIS2 AML

Expanding the High-Risk Definition for Children with Newly Diagnosed Acute Myeloid Leukemia

Characteristics and Prognostic Effects of IDH Mutations across the Age Spectrum in AML: A Collaborative Analysis from COG, SWOG, and ECOG

Temporal Trends in Early Mortality in Acute Promyelocytic Leukemia in the United States

Outcomes Based on CNS Disease Status in Pediatric Acute Myeloid Leukemia and the Role of Peripheral Blood Contamination in Diagnostic Lumbar Punctures; A Report from the Children's Oncology Group Studies AAML0531 and AAML1031

Targeting PRMT1 As a Novel Curative Therapy for Acute Myeloid Leukemia

Genomic Subtypes of Nucleophosmin (NPM1) Mutations Are Associated with Clinical Outcome in AML - a COG and SWOG Intergroup Collaboration

FLT3 Mutations in Pediatric Acute Promyelocytic Leukemia; A Report from the Children's Oncology Group AAML0631 Trial

Malignancy Risk Markers in a Cohort of Referrals for Lymphadenopathy; An Evaluation of Clinical Features Including Lymph Node Size

TET2 Mutations Are Highly Associated with RUNX1-RUNX1T1 Translocations and NPMc+ in Childhood AML: a Report from Children's Oncology Group AAML03P1, AAML0531 and NCI/COG Target AML Initiative

Defining the Genomic Make up of Acute Myeloid Leukemia in Adolescents and Young Adults (AYA): Report from COG AAML03P1, AAML531 and SWOG S0106

Results of a Phase III Trial Including Arsenic Trioxide Consolidation for Pediatric Patients with Acute Promyelocytic Leukemia (APL): A Report from the Children's Oncology Group Study AAML0631

Comprehensive Genomic and Transcript Profiling of CBL Gene in Childhood AML: A Report from Children's Oncology Group Studies AAML03P1, AAML0531 and COG/NCI Target AML Initiative

Arsenic Trioxide Is a Well Tolerated Consolidation Regimen in Children with Newly Diagnosed Acute Promyelocytic Leukemia; Toxicity Results of the Children’s Oncology Group AAML0631 Trial

Effect of Young Age on Outcomes in Pediatric Acute Promyelocytic Leukemia (APL): North American Intergroup Study CALGB 9710 (Alliance)

A Comparison of Outcomes Between Adolescents and Young Adults (AYA) and Children with Acute Promyelocytic Leukemia (APL): North American Intergroup Study CALGB 9710 (Alliance)

Incidence and Outcomes of Pediatric Myelodysplastic Syndrome in the US

Evaluation of ISTH DIC Score to Predict Significant Bleeding and Thrombosis Events in Pediatric Acute Promyelocytic Leukemia; A Report from the Children’s Oncology Group AAML0631 Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only